ICI Archives

Simple blood tests could predict immunotherapy effectiveness

Written by

Dr George Laliotis and his team predict the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy using precision-medicine techniques.

Despite the extensive use of immunotherapy in patients suffering from head and neck squamous cell carcinoma, this therapy has significant limitations. Not everyone responds to treatment and current therapies can have serious adverse side effects. When working at the Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, USA, Dr George Laliotis and his team discovered that biochemical factors, measured […]

Probing Cancer: Immunotherapy and Molecular Imaging

Written by

Dr Robins researches novel immune checkpoint inhibitor (ICI) therapies.

The Singapore-based Cancer ImmunoTherapy Imaging (CITI) programme is a Singapore-wide collaborative research group, comprising 12 research institutes. CITI’s efforts are focused on the discovery and application of peptide-based imaging probes, which target immunotherapy treatment response biomarkers. Dr Edward G Robins, Head of Radiochemistry at the Singapore Bioimaging Consortium and Deputy Director of the NUS Clinical Imaging Research Centre, alongside his […]